Authors


Anuj Chauhan, PhD

Latest:

Combination glaucoma therapy by drug-eluting lenses

In this article, the authors present their recent findings on drug-eluting, extended-wear contact lenses for glaucoma and discuss how these lenses may provide week-long IOP reduction with just one day of wear.


Steven C. Schallhorn, MD

Latest:

Cutting-edge LASIK technologies in quest for perfect vision

Take-home message: The various excimer ablation technologies have their pros and cons. Wavefront-guided ablations using aberrometry can provide the vast majority of patients with uncorrected vision of 20/20 with fewer postoperative visual symptoms.


Betty Lorente, MD

Latest:

CTR does not avert spontaneous IOL dislocation

In what is believed to be the largest reported series of spontaneous in-the-bag IOL dislocation, investigators analyze presenting characteristics and outcomes for 21 eyes with a capsular tension ring (CTR) and 84 eyes without one.


Valentina Sarao, MD

Latest:

Advice on choosing AREDS or AREDS 2 in non-smokers

In this article, the authors discuss the benefits of nutritional supplementation in preventing AMD progression and consider which AREDS formulation is the most appropriate in smokers and non-smokers.


Kent Small, MD

Latest:

Lasting effects of anti-VEGF/photodynamic therapy for AMD

The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.


Erica Guerreiro Paulo, MD

Latest:

Real-world experience: Case study shows maintained benefits with FAc in DME patient

In the case study discussed in this article, a patient who was treated for DME with a fluocinolone acetonide intravitreal implant reported improved vision-related quality of life and the ability to perform daily routines without problems. These benefits persisted 12-months after treatment.


Rosemary Silva-Garcia, MD

Latest:

Lasting effects of anti-VEGF/photodynamic therapy for AMD

The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.


Bushra Mushtaq, FRCS

Latest:

Real-world experience: Positive DME treatment outcomes observed with FAc implant at UK centre

Dr Mushtaq discusses one centre’s initial post-marketing experience with the fluocinolone acetonide intravitreal implant 0.19 mg. The implant demonstrated favourable outcomes and good patient acceptance.


Fadi Shaya

Latest:

Lasting effects of anti-VEGF/photodynamic therapy for AMD

The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.


Colleen McLellan

Latest:

Lasting effects of anti-VEGF/photodynamic therapy for AMD

The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.


Arthur Cummings, FRCSEd

Latest:

New refractive technologies: early experiences, thoughts

Shortcomings in ablative procedures mean that new developments in refractive surgery are welcome. Arthur Cummings, MD, FRCSEd, reviews two new technologies that will increase patient satisfaction.


Shimon Rumelt, MD

Latest:

Filtration device lowers IOP in patients with PEG and POAG

A glaucoma filtration device was equally effective in reducing IOP in pseudoexfoliative glaucoma and primary open-angle glaucoma patients, in a recent small study.


Quang H. Nguyen, MD

Latest:

MIGS stent yields good IOP control as stand-alone treatment

Microstent implantation had favorable and safe results in a group of patients with open-angle glaucoma in the DUETTE trial.


Yash Vaishnav

Latest:

Mobile EHR photos brings instant visualization of clinical images

Capturing clinical images with the integration of electronic health records and smartphone applications can enhance practice efficiency and compliance.


Michael Ehrlich, MD

Latest:

Mobile EHR photos brings instant visualization of clinical images

Capturing clinical images with the integration of electronic health records and smartphone applications can enhance practice efficiency and compliance.



Jeffrey L. Goldberg, MD, PhD

Latest:

Therapeutic advances in glaucoma focus on retinal ganglion cell pathology

Findings from basic science research elucidating the mechanisms of retinal ganglion cell axon degeneration, regeneration, and death have identified new therapeutic targets for glaucoma that are being investigated in preclinical and clinical studies.


Burkhard Dick, MD

Latest:

Anterior capsulotomy is the main prostaglandin release inducer in FLACS

Research presented in this article found anterior capsulotomy to be the main trigger for an increase of prostaglandins in aqueous humor immediately after laser-assisted cataract surgery. Optimised energy settings in combination with NSAIDs might therefore help reduce laser-induced miosis.


Burkhard Dick, MD, PhD

Latest:

Bladeless, custom FLACS technology: What's in a name?

A small review recently found 28 different names for the procedure, and the chances are there are even more currently in use.


Julie Gough-Nelson

Latest:

Are you reaching the right audience? Identifying when change is necessary

The title of this blog may have you answering in the affirmative -after all, working in medicine is all about the patients, right?


Beth Hertz

Latest:

6 things PCPs should know about glaucoma

Glaucoma is a leading cause of blindness, a problem which is made even more serious by the fact that many patients do not notice any symptoms until it is too late to prevent permanent blindness.


Roberto Pineda, MD

Latest:

Pupil expander manages unique needs of small pupils

A pupil expansion device is flexible, yet stable and can easily be inserted and removed for cataract surgery procedures.


Kevin J. Blinder, MD

Latest:

Anti-VEGF patterns of use for DME may vary in clinical practice

Though anti-vascular endothelial growth factor therapy for diabetic macular edema showed impressive results in trials, clinicians have reported less success on their own.


Michelle Dalton, ELS

Latest:

Research Scholar Honoree Program draws global interest amid pandemic

Fellows, residents from around the world show promise for future of retinal research.


Keith Warren, MD

Latest:

Key strategies for treating postsurgical CME

Cystoid macular edema can permanently alter vision, so it is highly crucial to utilize best practices for treating the cataract surgery complication.


Justis P. Ehlers, MD

Latest:

Technologic advances integrate OCT into real-time surgeries

Researchers are conducting a prospective, multisurgeon, single-center study to evaluate multiple microscope integrated-prototypes with real-time surgeon feedback.


Tibor Lohmann, MD

Latest:

New wide-field, dual-array, suprachoroidal-transretinal stimulation prosthesis demonstrates surgical feasibility

Prof. Fujikado presents his research, which demonstrated the surgical feasibility and safety of a newly developed, dual-array, suprachoroidal-transretinal stimulation prosthesis in animals. The dual-array design was able to activate retinal neurons and optic nerve axons. Findings indicate the future possibility of activating of a larger visual field with the prosthesis.


Takashi Fujikado, MD, PhD

Latest:

New wide-field, dual-array, suprachoroidal-transretinal stimulation prosthesis demonstrates surgical feasibility

Prof. Fujikado presents his research, which demonstrated the surgical feasibility and safety of a newly developed, dual-array, suprachoroidal-transretinal stimulation prosthesis in animals. The dual-array design was able to activate retinal neurons and optic nerve axons. Findings indicate the future possibility of activating of a larger visual field with the prosthesis.


Joshua Mali, MD

Latest:

Looking ahead: 2024 shaping up to be an interesting year

Joshua Mali, MD, offers up his predictions for ophthalmology in 2024.


Lawrence Tychsen, MD

Latest:

Refractive surgery for special needs children: The time is now

The time for refractive surgery for special needs children seems to be at hand, considering that advancements in laser and IOL technologies have been proven to be efficacious. Correcting a special needs child’s vision can reduce fearfulness and improve their behavioral challenges.

© 2024 MJH Life Sciences

All rights reserved.